3
Announcements
Trials
Browse
Landscape
Status
Not yet recruiting
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
15
Breast
12
Other
6
Thoracic
4
Endocrine
4
Other hematologic neoplasm
3
Lymphoid
3
Genitourinary
3
CNS
2
Sarcoma
1
Myeloid
1
Gynecologic
1
Dermatologic
1
Classical hematology
1
Conditions
Sarcoma
727
Glioblastoma
354
Gliosarcoma
341
Brain Neoplasms
254
Central Nervous System Neoplasms
223
Astrocytoma
204
Osteosarcoma
202
Gastrointestinal Stromal Tumors
176
Dendritic Cell Sarcoma, Interdigitating
174
Glioma
165
Lymphoma
163
Burkitt Lymphoma
162
Precursor Cell Lymphoblastic Leukemia-Lymphoma
158
Neoplasms
155
Lymphoma, Non-Hodgkin
151
Oligodendroglioma
147
Recurrence
138
Lymphoma, Large B-Cell, Diffuse
133
Neuroblastoma
130
Lymphoma, Follicular
127
Breast Neoplasms
121
Leukemia, Lymphocytic, Chronic, B-Cell
120
Lymphoma, Mantle-Cell
119
Leukemia
116
Lymphoma, B-Cell, Marginal Zone
113
Lymphoma, Large-Cell, Immunoblastic
112
Rhabdomyosarcoma
111
Hodgkin Disease
110
Bone Neoplasms
109
Sarcoma, Kaposi
102
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Inflammation
×
Sarcoma
×
Clear all
NCT02107664
2019-03-22
PRAIS
Norwegian University of Science and Technology
Completed
580 enrolled